Dissecting Direct Reprogramming from Fibroblast to Neuron Using Single-Cell RNA-Seq Barbara Treutlein1,2*, Qian Yi Lee1,3,4*, J

Total Page:16

File Type:pdf, Size:1020Kb

Dissecting Direct Reprogramming from Fibroblast to Neuron Using Single-Cell RNA-Seq Barbara Treutlein1,2*, Qian Yi Lee1,3,4*, J LETTER doi:10.1038/nature18323 Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq Barbara Treutlein1,2*, Qian Yi Lee1,3,4*, J. Gray Camp5, Moritz Mall3,4, Winston Koh1, Seyed Ali Mohammad Shariati6, Sopheak Sim3, Norma F. Neff1, Jan M. Skotheim6, Marius Wernig3,4§ & Stephen R. Quake1,7,8§ Direct lineage reprogramming represents a remarkable with Ascl1 only (hereafter referred to as Ascl1-only cells) using PCA conversion of cellular and transcriptome states1–3. However, and identified three distinct clusters (A, B, C), which correlated with the the intermediate stages through which individual cells progress level of Ascl1 expression (Fig. 1b–e). Cluster A consisted of all control during reprogramming are largely undefined. Here we use single- d0 MEFs and a small fraction of day 2 cells (~ 12%) which showed cell RNA sequencing4–7 at multiple time points to dissect direct no detectable Ascl1 expression, suggesting these day 2 cells were not reprogramming from mouse embryonic fibroblasts to induced infected with the Ascl1 virus. This is consistent with typical Ascl1 neuronal cells. By deconstructing heterogeneity at each time infection efficiencies of about 80–90%. We found that the day 0 MEFs point and ordering cells by transcriptome similarity, we find that were surprisingly homogeneous, with much of the variance due to cell the molecular reprogramming path is remarkably continuous. cycle (Extended Data Fig. 1b–g, Supplementary Data 3, Supplementary Overexpression of the proneural pioneer factor Ascl1 results in a Information). Cluster C was characterized by high expression of Ascl1, well-defined initialization, causing cells to exit the cell cycle and Ascl1-target genes (Zfp238, Hes6, Atoh8 and so on) and genes involved re-focus gene expression through distinct neural transcription in neuron remodelling, as well as the downregulation of genes involved factors. The initial transcriptional response is relatively in cell cycle and mitosis (Fig. 1c, e, f and Supplementary Data 2). homogeneous among fibroblasts, suggesting that the early steps Cluster B cells represent an intermediate population that expressed are not limiting for productive reprogramming. Instead, the Ascl1 at a low level, and were characterized by a weaker upregulation later emergence of a competing myogenic program and variable of Ascl1-target genes and less efficient downregulation of cell cycle transgene dynamics over time appear to be the major efficiency genes compared to cluster C cells. This suggests that an Ascl1 expres- limits of direct reprogramming. Moreover, a transcriptional state, sion threshold is required to productively initiate the reprogramming distinct from donor and target cell programs, is transiently induced process. In addition, we found that forced Ascl1 expression resulted in in cells undergoing productive reprogramming. Our data provide less intracellular transcriptome variance, a lower number of expressed a high-resolution approach for understanding transcriptome states genes (Fig. 1d) and a lower total number of transcripts per single cell during lineage differentiation. (Extended Data Fig. 2a, b). Notably, the distribution of average expres- Direct lineage reprogramming bypasses an induced pluripotent stage sion levels per gene was similar for all experiments independent of to directly convert somatic cell types. Using the three transcription Ascl1 overexpression (Extended Data Fig. 2c). We observed that the factors Ascl1, Brn2 and Myt1l (BAM), mouse embryonic fibroblasts upregulation of neuronal targets and downregulation of cell cycle genes (MEFs) can be directly reprogrammed to induced neuronal (iN) cells in response to Ascl1 expression are uniform, indicating that the initial within 2 to 3 weeks at an efficiency of up to 20%8. Several groups have transcriptional response to Ascl1 is relatively homogenous among all further developed this conversion using transcription factor combi- cells (Fig. 1e). This suggests that most fibroblasts are initially competent nations that almost always contain Ascl1 (refs 9–12). Recently, one of to reprogram and later events must be responsible for the moderate our groups showed that Ascl1 is an ‘on target’ pioneer factor initiating reprogramming efficiency of about 20%. the reprogramming process13, and inducing conversion of MEFs into To explore the effect of transgene copy number variation on the functional iN cells alone, albeit at a much lower efficiency compared heterogeneity of the early response, we analysed single-cell tran- to BAM14. These findings raised the question whether and when a scriptomes of an additional 47 cells induced with Ascl1 for two days heterogeneous cellular response to the reprogramming factors occurs from secondary MEFs derived via blastocyst injection from a clonal, during reprogramming and which mechanisms might cause failure Ascl1-inducible embryonic stem cell line. As expected, the induction of reprogramming. We hypothesized that single-cell RNA sequencing efficiency of Ascl1 was 100% since the secondary MEFs are genetically (RNA-seq) could be used as a high-resolution approach to reconstruct identical and all cells carry the transgene in the same genomic location the reprogramming path of MEFs to iN cells and uncover mechanisms (Fig. 1g). Nevertheless, these clonal MEFs had similar transcriptional limiting reprogramming efficiencies4,15,16. responses and heterogeneity as primary infected MEFs at the day 2 time In order to understand transcriptional states during direct conver- point, as well as comparable reprogramming efficiencies and maturation sion between somatic fates, we measured 405 single-cell transcriptomes (Extended Data Fig. 3a). Finally, we compared the early response in our (Supplementary Data 1) at multiple time points during iN cell repro- Ascl1-only single-cell RNA-seq data with our previously reported bulk gramming (Fig. 1a and Extended Data Fig. 1a). We first explored how RNA-seq data of Ascl1-only and BAM-mediated reprogramming13 individual cells respond to Ascl1 overexpression during the initial phase (Extended Data Fig. 3b). We found similar downregulation of MEF- of reprogramming. We analysed day 0 MEFs and day 2 cells induced related genes and upregulation of pro-neural marker genes in both 1Department of Bioengineering, Stanford University, Stanford, California 94305, USA. 2Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Leipzig 04103, Germany. 3Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, USA. 4Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA. 5Department of Developmental Biology, Stanford University School of Medicine, Stanford, California 94305, USA. 6Department of Biology, Stanford University, Stanford, California 94305, USA. 7Howard Hughes Medical Institute, Stanford, California 94305 USA. 8Department of Applied Physics, Stanford University, Stanford, California 94305, USA. *These authors contributed equally to this work. §These authors jointly supervised this work. 00 MONTH 2016 | VOL 000 | NATURE | 1 © 2016 Macmillan Publishers Limited. All rights reserved RESEARCH LETTER + − a Single-cell RNA-seq measurements b Cluster C BA 40 Tau–eGFP and 15 Tau–eGFP cells for transcriptome analysis − d0 d2 d5 d22 25 by fluorescence-activated cell sorting. We found that Tau–eGFP BAM cells lacked expression of neuronal Ascl1-target genes (genes B), and Ascl1 0 MEF Infected Clonal Tau–eGFP+ iN cell maintained expression of fibroblast-associated genes (genes A and C; + –25 Tau–eGFP– Fig. 2a, b, Extended Data Fig. 4a, Supplementary Data 4). In addition, PC2 (2.11%) d0 2 d2 we found a positive correlation (R =​ 0.49) between Ascl1 expres- c 25 d 2.0 ×10–4 A sion and Tau–eGFP intensities (Extended Data Fig. 4b, Fig. 2a, b). y Ascl1 6.0 B log 0 Quantitative real-time (qRT)–PCR and western blot analysis of Ascl1 1.5 2 C [FPKM] 5 4.0 expression on day 5 to day 12 Tau–eGFP-sorted cells validated a 1.0 − –25 0 significant decrease in Ascl1 expression in Tau–eGFP cells compared 0.5 2.0 d0 PC2 (2.11%) + d2 Single cell densit to Tau–eGFP cells (Fig. 2c, Supplementary Data 5). Thus, Ascl1 0 0 –50 –25 025 3.0 4.0 5.0 3,000 5,000 7,000 expression is correlated to Tau–eGFP levels and expression of neu- PC1 (12.58%) Transcriptome variance No. of expressed genes ronal genes at day 5. This raises the hypothesis that Ascl1 is silenced e Genes I Genes II in cells that fail to reprogram. Alternatively, cells with low or no Ascl1 Cluster expression at day 5 and day 22 might have never highly expressed A Ascl1. To distinguish between these two mechanisms, we used live cell Cluster microscopy to track cells over a time course from 3–6 days after Ascl1 B induction using an eGFP–Ascl1 fusion construct (Fig. 2d, Extended Cluster C Data Fig. 5). We immunostained the cells at day 6 using Tuj1 antibod- ies recognizing the neuronal β 3-tubulin (Tubb3) to identify cells that 1 5 3 3 d0 b 0 12 d2 Tcf4 Sox9 Snca Cav1 Hes6 Birc Cnn2 Ascl Pval log [FPKM] Tcf12 differentiated towards neuronal fate. We found that transgenic Ascl1 Atoh8 2 Foxp2 Tubb Cdca Ube2c Zfp238 Hmga2 Ppp3ca protein levels varied substantially over time and, on average, contin- f Genes I –log10[P value] Genes II –log10[P value] g Single + 0 10 0 10 cells d0 MEF ued to increase over time in Tuj1 cells, but decreased or plateaued Translation Reg. pol II transcription − y 20 d2 Ascl1 Cell division Reg. gene expression infected in Tuj1 cells, leading to a significant difference in Ascl1 expression M phase Striated muscle dev. 10 d2 Ascl1 Cell cycle Reg. exc. memb. pot. clonal within six days of Ascl1 induction (Fig. 2e, Extended Data Fig. 4c). Rnp complex Axon Densit 0 –0.10 0.1 Organelle Cell projection BP This time-lapse analysis demonstrated that Ascl1 is silenced in many Ribosome Neuron projection CC PC1 loadings cells that fail to reprogram. Figure 1 | Ascl1 overexpression elicits a homogeneous early response We next analysed the maturation events occurring during late and initiates expression of neuronal genes.
Recommended publications
  • Table S1. List of Proteins in the BAHD1 Interactome
    Table S1. List of proteins in the BAHD1 interactome BAHD1 nuclear partners found in this work yeast two-hybrid screen Name Description Function Reference (a) Chromatin adapters HP1α (CBX5) chromobox homolog 5 (HP1 alpha) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins (20-23) HP1β (CBX1) chromobox homolog 1 (HP1 beta) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins HP1γ (CBX3) chromobox homolog 3 (HP1 gamma) Binds histone H3 methylated on lysine 9 and chromatin-associated proteins MBD1 methyl-CpG binding domain protein 1 Binds methylated CpG dinucleotide and chromatin-associated proteins (22, 24-26) Chromatin modification enzymes CHD1 chromodomain helicase DNA binding protein 1 ATP-dependent chromatin remodeling activity (27-28) HDAC5 histone deacetylase 5 Histone deacetylase activity (23,29,30) SETDB1 (ESET;KMT1E) SET domain, bifurcated 1 Histone-lysine N-methyltransferase activity (31-34) Transcription factors GTF3C2 general transcription factor IIIC, polypeptide 2, beta 110kDa Required for RNA polymerase III-mediated transcription HEYL (Hey3) hairy/enhancer-of-split related with YRPW motif-like DNA-binding transcription factor with basic helix-loop-helix domain (35) KLF10 (TIEG1) Kruppel-like factor 10 DNA-binding transcription factor with C2H2 zinc finger domain (36) NR2F1 (COUP-TFI) nuclear receptor subfamily 2, group F, member 1 DNA-binding transcription factor with C4 type zinc finger domain (ligand-regulated) (36) PEG3 paternally expressed 3 DNA-binding transcription factor with
    [Show full text]
  • Impairments in Contractility and Cytoskeletal Organisation Cause Nuclear Defects in Nemaline Myopathy
    bioRxiv preprint doi: https://doi.org/10.1101/518522; this version posted January 28, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy Jacob A Ross1, Yotam Levy1, Michela Ripolone2, Justin S Kolb3, Mark Turmaine4, Mark Holt5, Maurizio Moggio2, Chiara Fiorillo6, Johan Lindqvist3, Nicolas Figeac5, Peter S Zammit5, Heinz Jungbluth5,7,8, John Vissing9, Nanna Witting9, Henk Granzier3, Edmar Zanoteli10, Edna C Hardeman11, Carina Wallgren- Pettersson12, Julien Ochala1,5. 1. Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, Guy’s Campus, King’s College London, SE1 1UL, UK 2. Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan 20122, Italy 3. Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona, 85721, USA 4. Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK 5. Randall Centre for Cell and Molecular Biophysics, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, Guy’s Campus, King’s College London, SE1 1UL, UK 6. Molecular Medicine, IRCCS Fondazione Stella Maris, Pisa and Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genoa, Italy 7. Department of Paediatric Neurology, Neuromuscular Service, Evelina's Children Hospital, Guy's and St Thomas' Hospital National Health Service Foundation Trust, London, SE1 9RT, UK 8. Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, SE1 1UL, UK 9.
    [Show full text]
  • An Integrative Study
    Published OnlineFirst January 12, 2010; DOI: 10.1158/1535-7163.MCT-09-0321 Molecular Spotlight on Molecular Profiling Cancer Therapeutics Multifactorial Regulation of E-Cadherin Expression: An Integrative Study William C. Reinhold1, Mark A. Reimers1,2, Philip Lorenzi1,3, Jennifer Ho1, Uma T. Shankavaram1,4, Micah S. Ziegler1, Kimberly J. Bussey1,5, Satoshi Nishizuka1,6, Ogechi Ikediobi1,7, Yves G. Pommier1, and John N. Weinstein1,3 Abstract E-cadherin (E-cad) is an adhesion molecule associated with tumor invasion and metastasis. Its down- regulation is associated with poor prognosis for many epithelial tumor types. We have profiled E-cad in the NCI-60 cancer cell lines at the DNA, RNA, and protein levels using six different microarray platforms plus bisulfite sequencing. Here we consider the effects on E-cad expression of eight potential regulatory factors: E-cad promoter DNA methylation, the transcript levels of six transcriptional repressors (SNAI1, SNAI2, TCF3, TCF8, TWIST1, and ZFHX1B), and E-cad DNA copy number. Combined bioinformatic and pharmacological analyses indicate the following ranking of influence on E-cad expression: (1) E-cad pro- moter methylation appears predominant, is strongly correlated with E-cad expression, and shows a 20% to 30% threshold above which E-cad expression is silenced; (2) TCF8 expression levels correlate with (−0.62) and predict (P < 0.00001) E-cad expression; (3) SNAI2 and ZFHX1B expression levels correlate positively with each other (+0.83) and also correlate with (−0.32 and −0.30, respectively) and predict (P =0.03and 0.01, respectively) E-cad expression; (4) TWIST1 correlates with (−0.34) but does not predict E-cad expres- sion; and (5) SNAI1 expression, TCF3 expression, and E-cad DNA copy number do not correlate with or predict E-cad expression.
    [Show full text]
  • Prospective Isolation of NKX2-1–Expressing Human Lung Progenitors Derived from Pluripotent Stem Cells
    The Journal of Clinical Investigation RESEARCH ARTICLE Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells Finn Hawkins,1,2 Philipp Kramer,3 Anjali Jacob,1,2 Ian Driver,4 Dylan C. Thomas,1 Katherine B. McCauley,1,2 Nicholas Skvir,1 Ana M. Crane,3 Anita A. Kurmann,1,5 Anthony N. Hollenberg,5 Sinead Nguyen,1 Brandon G. Wong,6 Ahmad S. Khalil,6,7 Sarah X.L. Huang,3,8 Susan Guttentag,9 Jason R. Rock,4 John M. Shannon,10 Brian R. Davis,3 and Darrell N. Kotton1,2 2 1Center for Regenerative Medicine, and The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA. 3Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, Texas, USA. 4Department of Anatomy, UCSF, San Francisco, California, USA. 5Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. 6Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA. 7Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA. 8Columbia Center for Translational Immunology & Columbia Center for Human Development, Columbia University Medical Center, New York, New York, USA. 9Department of Pediatrics, Monroe Carell Jr. Children’s Hospital, Vanderbilt University, Nashville, Tennessee, USA. 10Division of Pulmonary Biology, Cincinnati Children’s Hospital, Cincinnati, Ohio, USA. It has been postulated that during human fetal development, all cells of the lung epithelium derive from embryonic, endodermal, NK2 homeobox 1–expressing (NKX2-1+) precursor cells.
    [Show full text]
  • Defining Functional Interactions During Biogenesis of Epithelial Junctions
    ARTICLE Received 11 Dec 2015 | Accepted 13 Oct 2016 | Published 6 Dec 2016 | Updated 5 Jan 2017 DOI: 10.1038/ncomms13542 OPEN Defining functional interactions during biogenesis of epithelial junctions J.C. Erasmus1,*, S. Bruche1,*,w, L. Pizarro1,2,*, N. Maimari1,3,*, T. Poggioli1,w, C. Tomlinson4,J.Lees5, I. Zalivina1,w, A. Wheeler1,w, A. Alberts6, A. Russo2 & V.M.M. Braga1 In spite of extensive recent progress, a comprehensive understanding of how actin cytoskeleton remodelling supports stable junctions remains to be established. Here we design a platform that integrates actin functions with optimized phenotypic clustering and identify new cytoskeletal proteins, their functional hierarchy and pathways that modulate E-cadherin adhesion. Depletion of EEF1A, an actin bundling protein, increases E-cadherin levels at junctions without a corresponding reinforcement of cell–cell contacts. This unexpected result reflects a more dynamic and mobile junctional actin in EEF1A-depleted cells. A partner for EEF1A in cadherin contact maintenance is the formin DIAPH2, which interacts with EEF1A. In contrast, depletion of either the endocytic regulator TRIP10 or the Rho GTPase activator VAV2 reduces E-cadherin levels at junctions. TRIP10 binds to and requires VAV2 function for its junctional localization. Overall, we present new conceptual insights on junction stabilization, which integrate known and novel pathways with impact for epithelial morphogenesis, homeostasis and diseases. 1 National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK. 2 Computing Department, Imperial College London, London SW7 2AZ, UK. 3 Bioengineering Department, Faculty of Engineering, Imperial College London, London SW7 2AZ, UK. 4 Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
    [Show full text]
  • Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Co-Regulator in Invasive 6 Lobular Carcinoma of the Breast 7 8 Evelyn K
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.16.423142; this version posted December 16, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Running Title: MDC1 co-regulates ER in ILC 2 3 Research article 4 5 Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive 6 lobular carcinoma of the breast 7 8 Evelyn K. Bordeaux1+, Joseph L. Sottnik1+, Sanjana Mehrotra1, Sarah E. Ferrara2, Andrew E. Goodspeed2,3, James 9 C. Costello2,3, Matthew J. Sikora1 10 11 +EKB and JLS contributed equally to this project. 12 13 Affiliations 14 1Dept. of Pathology, University of Colorado Anschutz Medical Campus 15 2Biostatistics and Bioinformatics Shared Resource, University of Colorado Comprehensive Cancer Center 16 3Dept. of Pharmacology, University of Colorado Anschutz Medical Campus 17 18 Corresponding author 19 Matthew J. Sikora, PhD.; Mail Stop 8104, Research Complex 1 South, Room 5117, 12801 E. 17th Ave.; Aurora, 20 CO 80045. Tel: (303)724-4301; Fax: (303)724-3712; email: [email protected]. Twitter: 21 @mjsikora 22 23 Authors' contributions 24 MJS conceived of the project. MJS, EKB, and JLS designed and performed experiments. JLS developed models 25 for the project. EKB, JLS, SM, and AEG contributed to data analysis and interpretation. SEF, AEG, and JCC 26 developed and performed informatics analyses. MJS wrote the draft manuscript; all authors read and revised the 27 manuscript and have read and approved of this version of the manuscript.
    [Show full text]
  • Human Periprostatic Adipose Tissue: Secretome from Patients With
    CANCER GENOMICS & PROTEOMICS 16 : 29-58 (2019) doi:10.21873/cgp.20110 Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia PAULA ALEJANDRA SACCA 1, OSVALDO NÉSTOR MAZZA 2, CARLOS SCORTICATI 2, GONZALO VITAGLIANO 3, GABRIEL CASAS 4 and JUAN CARLOS CALVO 1,5 1Institute of Biology and Experimental Medicine (IBYME), CONICET, Buenos Aires, Argentina; 2Department of Urology, School of Medicine, University of Buenos Aires, Clínical Hospital “José de San Martín”, Buenos Aires, Argentina; 3Department of Urology, Deutsches Hospital, Buenos Aires, Argentina; 4Department of Pathology, Deutsches Hospital, Buenos Aires, Argentina; 5Department of Biological Chemistry, School of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina Abstract. Background/Aim: Periprostatic adipose tissue Prostate cancer (PCa) is the second most common cancer in (PPAT) directs tumour behaviour. Microenvironment secretome men worldwide. While most men have indolent disease, provides information related to its biology. This study was which can be treated properly, the problem consists in performed to identify secreted proteins by PPAT, from both reliably distinguishing between indolent and aggressive prostate cancer and benign prostate hyperplasia (BPH) disease. Evidence shows that the microenvironment affects patients. Patients and Methods: Liquid chromatography-mass tumour behavior. spectrometry-based proteomic analysis was performed in Adipose tissue microenvironment is now known to direct PPAT-conditioned media (CM) from patients with prostate tumour growth, invasion and metastases (1, 2). Adipose cancer (CMs-T) (stage T3: CM-T3, stage T2: CM-T2) or tissue is adjacent to the prostate gland and the site of benign disease (CM-BPH). Results: The highest number and invasion of PCa.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Oxidative Stress Activates SIRT2 to Deacetylate and Stimulate Phosphoglycerate Mutase
    Published OnlineFirst May 1, 2014; DOI: 10.1158/0008-5472.CAN-13-3615 Cancer Tumor and Stem Cell Biology Research Oxidative Stress Activates SIRT2 to Deacetylate and Stimulate Phosphoglycerate Mutase Yanping Xu2,3, Fulong Li2,3, Lei Lv1,2, Tingting Li2,3, Xin Zhou2,3, Chu-Xia Deng4, Kun-Liang Guan1,2,5, Qun-Ying Lei1,2, and Yue Xiong1,2,6 Abstract Glycolytic enzyme phosphoglycerate mutase (PGAM) plays an important role in coordinating energy production with generation of reducing power and the biosynthesis of nucleotide precursors and amino acids. Inhibition of PGAM by small RNAi or small molecule attenuates cell proliferation and tumor growth. PGAM activity is commonly upregulated in tumor cells, but how PGAM activity is regulated in vivo remains poorly understood. Here we report that PGAM is acetylated at lysine 100 (K100), an active site residue that is invariably conserved from bacteria, to yeast, plant, and mammals. K100 acetylation is detected in fly, mouse, and human cells and in multiple tissues and decreases PGAM2 activity. The cytosolic protein deacetylase sirtuin 2 (SIRT2) deacetylates and activates PGAM2. Increased levels of reactive oxygen species stimulate PGAM2 deacetylation and activity by promoting its interaction with SIRT2. Substitution of endogenous PGAM2 with an acetylation mimetic mutant K100Q reduces cellular NADPH production and inhibits cell proliferation and tumor growth. These results reveal a mechanism of PGAM2 regulation and NADPH homeostasis in response to oxidative stress that impacts cell proliferation and tumor growth. Cancer Res; 74(13); 1–13. Ó2014 AACR. Introduction contains two PGAM genes, PGAM1 (also known as PGAM-B), Enhanced glycolysis, commonly referred to as the "Warburg which is expressed in brain and most other tissues, and PGAM2 effect" (1), is a distinctive and prominent feature of cancer cells.
    [Show full text]
  • Functional Characterisation of MYT1L, a Brain-Specific Transcriptional Regulator
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Functional characterisation of MYT1L, a brain-specific transcriptional regulator Kepa, Agnieszka Maria Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 04. Oct. 2021 Functional characterisation of MYT1L, a brain-specific transcriptional regulator Agnieszka Kępa 2014 A thesis submitted to King’s College London for the degree of Doctor of Philosophy MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry ABSTRACT Abnormalities in brain development and maladaptive plasticity are thought to underlay a range of neurodevelopmental and neurological disabilities and disorders, such as autism spectrum disorders, schizophrenia and learning disability.
    [Show full text]
  • Early-Onset Obesity and Paternal 2Pter Deletion Encompassing the ACP1, TMEM18,Andmyt1l Genes
    European Journal of Human Genetics (2014) 22, 471–479 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18,andMYT1L genes Martine Doco-Fenzy*,1, Camille Leroy1, Anouck Schneider2, Florence Petit3, Marie-Ange Delrue4, Joris Andrieux3, Laurence Perrin-Sabourin5, Emilie Landais1, Azzedine Aboura5, Jacques Puechberty2,6, Manon Girard6, Magali Tournaire6, Elodie Sanchez2, Caroline Rooryck4,Agne`s Ameil7, Michel Goossens8, Philippe Jonveaux9, Genevie`ve Lefort2,6, Laurence Taine4, Dorothe´e Cailley4, Dominique Gaillard1, Bruno Leheup10, Pierre Sarda2 and David Genevie`ve2 Obesity is a common but highly, clinically, and genetically heterogeneous disease. Deletion of the terminal region of the short arm of chromosome 2 is rare and has been reported in about 13 patients in the literature often associated with a Prader–Willi-like phenotype. We report on five unrelated patients with 2p25 deletion of paternal origin presenting with early- onset obesity, hyperphagia, intellectual deficiency, and behavioural difficulties. Among these patients, three had de novo pure 2pter deletions, one presented with a paternal derivative der(2)t(2;15)(p25.3;q26) with deletion in the 2pter region and the last patient presented with an interstitial 2p25 deletion. The size of the deletions was characterized by SNP array or array-CGH and was confirmed by fluorescence in situ hybridization (FISH) studies. Four patients shared a 2p25.3 deletion with a minimal critical region estimated at 1.97 Mb and encompassing seven genes, namely SH3HYL1, ACP1, TMEMI8, SNTG2, TPO, PXDN, and MYT1L genes. The fifth patient had a smaller interstitial deletion encompassing the TPO, PXDN, and MYT1L genes.
    [Show full text]
  • Myt1l Safeguards Neuronal Identity by Actively Repressing Many Non-Neuronal Fates Moritz Mall1, Michael S
    LETTER doi:10.1038/nature21722 Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates Moritz Mall1, Michael S. Kareta1†, Soham Chanda1,2, Henrik Ahlenius3, Nicholas Perotti1, Bo Zhou1,2, Sarah D. Grieder1, Xuecai Ge4†, Sienna Drake3, Cheen Euong Ang1, Brandon M. Walker1, Thomas Vierbuchen1†, Daniel R. Fuentes1, Philip Brennecke5†, Kazuhiro R. Nitta6†, Arttu Jolma6, Lars M. Steinmetz5,7, Jussi Taipale6,8, Thomas C. Südhof2 & Marius Wernig1 Normal differentiation and induced reprogramming require human Myt1l (Extended Data Fig. 1). Chromatin immunoprecipita- the activation of target cell programs and silencing of donor cell tion followed by DNA sequencing (ChIP–seq) of endogenous Myt1l programs1,2. In reprogramming, the same factors are often used to in fetal neurons (embryonic day (E) 13.5) and ectopic Myt1l in mouse reprogram many different donor cell types3. As most developmental embryonic fibroblasts (MEFs) two days after induction identified 3,325 repressors, such as RE1-silencing transcription factor (REST) and high-confidence Myt1l peaks that overlapped remarkably well between Groucho (also known as TLE), are considered lineage-specific neurons and MEFs (Fig. 1a, Extended Data Fig. 2, Supplementary repressors4,5, it remains unclear how identical combinations of Table 1). Thus, similar to the pioneer factor Ascl1, Myt1l can access transcription factors can silence so many different donor programs. the majority of its cognate DNA binding sites even in a distantly related Distinct lineage repressors would have to be induced in different cell type. However, unlike Ascl1 targets8, the chromatin at Myt1l donor cell types. Here, by studying the reprogramming of mouse fibroblasts to neurons, we found that the pan neuron-specific a Myt1l Myt1l b Myt1l Ascl1 Random Myt1l 6 Ascl1 + Brn2 endogenous transcription factor Myt1-like (Myt1l) exerts its pro-neuronal Closed 0.030 function by direct repression of many different somatic lineage k programs except the neuronal program.
    [Show full text]